EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spatial Omics Profiling of Treatment-Naïve Lung Adenocarcinoma with Brain Metastasis as the Initial Presentation

Seoyeon Gwon iD, Inju Cho, Jieun Lee iD, Seung Yun Lee iD, Kyue-Hee Choi iD, Tae-Jung Kim iD

Cancers · 31.07.2025 · 17 (15) · 2529

DOI: 10.3390/cancers17152529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 31.07.2025. Verfasst von Seoyeon Gwon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pathology, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul 07345, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Technology Innovation Program, Institute of Clinical Medicine Research in the Yeouido St. Mary’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Brain metastasis (BM) is a common and often early manifestation in lung adenocarcinoma (LUAD), yet its tumor microenvironment remains poorly defined at the time of initial diagnosis. This study aims to characterize early immune microenvironmental alterations in synchronous BM using spatial proteomic profiling.

Methods

We performed digital spatial proteomic profiling using the NanoString GeoMx platform on formalin-fixed paraffin-embedded tissues from five treatment-naïve LUAD patients in whom BM was the initial presenting lesion. Paired primary lung and brain metastatic samples were analyzed across tumor and stromal compartments using 68 immune- and tumor-related protein markers.

Results

Spatial profiling revealed distinct expression patterns between primary tumors and brain metastases. Immune regulatory proteins—including IDO-1, PD-1, PD-L1, STAT3, PTEN, and CD44—were significantly reduced in brain metastases (p < 0.01), whereas pS6, a marker of activation-induced T-cell death, was significantly upregulated (p < 0.01). These alterations were observed in both tumor and stromal regions, suggesting a more immunosuppressive and apoptotic microenvironment in brain lesions.

Conclusions

This study provides one of the first spatially resolved proteomic characterizations of synchronous BM at initial LUAD diagnosis. Our findings highlight early immune escape mechanisms and suggest the need for site-specific immunotherapeutic strategies in patients with brain metastasis.

Schlagwörter

Stichwörter der Autor:innen

CD44IDO-1PD1PDL1PTENSTAT3brain metastasisdigital spatial profilinglung cancer

Autor:innen und Institutionen

  • Department of Hospital Pathology, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul 07345, Republic of Korea.

ORCID-Profile: Seoyeon Gwon, Jieun Lee, Seung Yun Lee, Kyue-Hee Choi, Tae-Jung Kim

Förderung

  • Ministry of Trade, Industry and Energy
  • Technology Innovation Program
  • Institute of Clinical Medicine Research in the Yeouido St. Mary’s Hospital

Zitieren

APA

Gwon, S., Cho, I., Lee, J., Lee, S. Y., Choi, K. H., & Kim, T. J. (2025). Spatial Omics Profiling of Treatment-Naïve Lung Adenocarcinoma with Brain Metastasis as the Initial Presentation. Cancers, 17(15), 2529. https://doi.org/10.3390/cancers17152529

Vancouver

Gwon S, Cho I, Lee J, Lee SY, Choi KH, Kim TJ. Spatial Omics Profiling of Treatment-Naïve Lung Adenocarcinoma with Brain Metastasis as the Initial Presentation. Cancers. 2025;17(15):2529. doi:10.3390/cancers17152529

BibTeX
@article{Gwon2025,
  author = {Gwon, Seoyeon and Cho, Inju and Lee, Jieun and Lee, Seung Yun and Choi, Kyue-Hee and Kim, Tae-Jung},
  title = {Spatial Omics Profiling of Treatment-Naïve Lung Adenocarcinoma with Brain Metastasis as the Initial Presentation},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {15},
  pages = {2529},
  doi = {10.3390/cancers17152529}
}
Kostenlos starten →